Week 307 Review - Quiet week with some small recovery

Not an awful lot happened this week, but a slight recovery in some miners and a 2p increase in OPTI:Optibiotix led to a reduction in the deficit between cost and value of £3,270 to £27,352 and an increase in portfolio value to £117,443.

Only big loser was CMCL:Caledonia Mining which has been an utter disaster of an investment. Given most miners have increased, these have dropped 27% since I bought them and this week fell 7%.

FXPO:Ferrexpo did the opposite and recovered by 7%. They are only 1% down now, so fingers crossed will go back into profit next week.

Share of the Week was JLP:Jubilee Metals which climbed 18% of my original purchase price after a drop last week. They are 338% up and with the prospect of imminent news on copper production have a lot further to go yet.

I think that takes us slightly closer to the red line than the orange, but only just.

Well below the trend line which is getting flatter by the week.

Here's the ISA and shares portfolio after week 47 of year 6.

			Weekly Change
Cash	£39.08		+£0
Portfolio cost	£68,170.47		+£0
Portfolio sell value (bid price-commission)	£57,486.38	(-15.7%)	+£1,898.12
Potential profits	£7,324.08		+£400.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£3,697.33		+£0
Yr 6 projected avg monthly profit	£337.09	(9.2%)	-£7.32
Total Dividends	£1,343.15		+£0
Total Profit from sales	£24,123.94		+£0
Average monthly cash profit	£355.60	(9.7%)	-£1.16
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

A good week with potential profits for JLP:Jubilee Metals climbing by £400 and losses reducing by an additional £1,498.

Nice steep rise in this account. Might actually get to the trend line soon.

The SIPP looks like this after week 291 overall and week 31 of year 6.

			Weekly Change
Cash	£495.04		+£287.50
Portfolio cost	£73,458.48		+£0
Portfolio sell value (bid price - commission)	£57,762.54	(-21.4%)	+£1,415.73
Potential profits	£880.52		+£135.00
Yr 6 Dividends	£874.51		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£7,774.62		+£0
Yr 6 projected avg monthly profit	£1,192.62	(32.7%)	-£39.75
Total Dividends	£2,941.59		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£23,234.06		+£0
Average monthly cash profit	£378.80	(10.4%)	-£1.30
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	58%		+0%

Potential profits are up by £135 and that's all CAML:Central Asia Metals as everything else is making a loss after I sold all my magic formula shares. Cash went up by £287 due to a pension tax refund from recent contributions.

This account is normally the good one, but it's closer to the orange line than the ISA

The trend line is almost flat and we're still a long way below it.

The trading account looks like this after week 257 overall and week 49 of year 5.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,401.71	(-41.0%)	-£43.14
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£58.69	(29.7%)	-£1.23
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£16.83	(8.5%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

Everything dropped in value this week so things are looking pretty bad. Only 3 weeks until the end of Year 5 which will be my best ever year for this account.

Almost at the injection line. This needs a rocket up it.

Absolutely desperate.

I'm hoping the 2p rise in OPTI:Optibiotix is a precursor to it being given a chance to go on a run. Normally it gets stifled mercilessly, but it's about time we were given something to smile about.

Week 306 Review - Nearly everything drops and Motif Bio written off

An absolutely rubbish week with big losses all over the place, especially the miners. Thankfully OPTI:Optibiotix stayed flat else things would have been even worse. However, thanks to writing off MTFB:Motif Bio as a loss, the deficit between cost and value actually narrowed by £583, but overall portfolio value dropped by about £2,000 to £113,885.

CAML:Central Asia Metals was the biggest faller, and after a 9% drop last week it fell another 15% this week. It looks like there is a drop across the mining sector, but none of my others dropped this much. Metal prices have dropped, but surely this is a blip, as there are shortages of supply across the board.

FXPO:Ferrexpo dropped 10% confirming the timing of my re-entry was utterly dreadful.

JLP:Jubilee Metals fell 7%, but we should get this back as soon as news of copper production breaks, and 7% is a remarkably small change compared to what I usually get.

TLOU:Tlou Energy also dropped 7% but I have no idea why.

CEY:Centamin was another recent purchase and dropped 6% this week to go 9% down already.

POLY:Polymetal also dropped by a large sum, falling 5% as the gold price is falling.

There was only one share that gained in price this week, so RDT:Rosslyn Data would have won Share of the Week even if it was only up by a percent. It was actually up by 7% and some hope is re-kindled that maybe one day I can sell at a profit.

Everything pointing downwards

Pointing upwards thanks to writing off a loss.

Here's the ISA and shares portfolio after week 46 of year 6.

			Weekly Change
Cash	£39.08		+£0
Portfolio cost	£68,170.47		-£2,521.19
Portfolio sell value (bid price-commission)	£55,588.26	(-18.5%)	-£396.48
Potential profits	£6,+24.08		-£150.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£3,697.33		-£2,521.19
Yr 6 projected avg monthly profit	£344.41	(9.4%)	-£250.44
Total Dividends	£1,343.15		+£0
Total Profit from sales	£24,123.94		-£2,521.19
Average monthly cash profit	£356.76	(9.8%)	-£36.99
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		-6%

The cost dropped by the £2,521 I had paid for MTFB:Motif Bio and which is almost certainly lost, as they have cancelled their AIM listing following a rejection of the 220:1 share consolidation and massive dilution of existing shareholders which was nothing short of a joke. Directors desperate to keep their salary and stuff the shareholders. Fortunately they didn't get away with it and the whole thing will almost certainly go bust. As a result I've written it off as a loss. This has wrecked my stellar Year 6 performance and brought long term performance down below my 10% target, but 9.4% for the year and 9.8% overall isn't bad, and it's a relief not to have to talk about the MTFB fiasco any more.

Aside from the write-off, JLP:Jubilee Metals dropped £150 to dent paper profits, and the rest of the portfolio also slipped by another £250 on top of that. It could have been much worse as we'll see in a minute with the SIPP.

Big drop in cost from the write-off, and value just down a small amount.

Big tick up as the write-off took away £2,500 worth of loss to narrow the deficit.

The SIPP looks like this after week 290 overall and week 30 of year 6.

			Weekly Change
Cash	£207.54		+£0.35
Portfolio cost	£73,458.48		+£282.97
Portfolio sell value (bid price - commission)	£56,346.81	(-23.3%)	-£1,487.07
Potential profits	£745.52		-£844.78
Yr 6 Dividends	£874.51		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£7,774.62		+£283.32
Yr 6 projected avg monthly profit	£1,232.37	(33.8%)	-£0.16
Total Dividends	£2,941.59		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£23,234.06		+£283.32
Average monthly cash profit	£380.10	(10.4%)	+£2.93
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	58%		+0%

I was depressed with everything dropping so flogged another 500 CAML;Central Asia Metals shares for 241.77p making £283.32 (30.6%) profit. I feel a bit bad that I've now sold so many, but they are drifting and there's no dividend for ages, whereas OPTI:Optibiotix is ludicrously under-valued so I had to get some more. I bought another 2,547 at 46.745p costing £1,199.55. My holding is now 163,299 giving me 13,299 I'm willing to sell and still keep 150,000 long term. My average price in the SIPP reduced to 60.78p compared to my ISA price of 60.4p. My holding is still down by £22,971 after 6 years, which is beyond frustrating, but my conviction these are going to be life changing is even stronger now, despite these losses.

Nearly everything in this portfolio got hammered, so value dropped by £1,487 and £844 of that was the huge drop in CAML:Cental Asia Metals, compounded by selling some.

Closer to the injection line than the cost line now

Really, really bad performance over the last 6 months. Possibly the worst ever for the SIPP.

The trading account looks like this after week 256 overall and week 48 of year 5.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,444.85	(-39.1%)	-£54.19
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£59.92	(30.3%)	-£1.27
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£16.89	(8.5%)	-£0.07
(Sold stocks profit + Dividends - Fees / Months)

Most of last week's gains were lost as everything dropped. Still happy that my long term performance is much better than a building society would have been - if I can sort out the fact that the portfolio itself is down by 39% which would wipe out the whole lot if I sold up now.

No sign of recovery, which is relying on good news from DDDD:4D Pharma because the rest is going nowhere fast.

Pretty bad.

So, OPTI:Optibiotix published results which most companies would have been proud of in a Covid year, but the results was absolutely no change in share price from the previous week. In fact, to add insult to injury SBTX:SkinBioTherapeutics climbed much more on the day OPTI released results than OPTI did. I'm just going to pout and sulk for a while and see what next week brings...

Week 305 Review - Yet another bad week but 4D Pharma starts to recover

I guess this is renowned as a bad time of year for share price value, but it's depressing when every time you claw some back, the following week it vanishes again. The deficit between cost and value widened by £3,342 this week to £31,206 and the portfolio value fell to £115,540. The crumb of comfort was that I cashed in a bit more profit.

The worst performer was JLP:Jubilee Metals which fell 30% of my purchase price, but at 327% up it's still my best performing share.

CAML:Central Asia Metals also had a bad week dropping 9%, and the few I sold this week were at an even lower price than that. They are still 42% up, but I've decided to reduce my holding a little as although it's a great company, the recent tailings dam leak shows that mining stocks are always risky and it's best to diversify. They still make up 2.5% of my portfolio, down from about 8% before I started selling. I may stop selling them now.

CMCL:Caledonia Mining dropped 6% in a bad week for all my mining stocks.

Share of the Week was the only significant riser. DDDD:4D Pharma climbed 10% but are still 17% down. I'm hoping this is the start of the recovery though.

I think for next week I can adjust this chart to start at £75K. The flat green line is deceptive due to the increases in both injection and cost.

This is a true reflection of the abject misery I'm feeling.

Here's the ISA and shares portfolio after week 45 of year 6.

			Weekly Change
Cash	£39.08		-£3.75
Portfolio cost	£70,691.67		+£0
Portfolio sell value (bid price-commission)	£55,984.74	(-20.8%)	-£1,720.61
Potential profits	£7,074.08		-£650.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£6,218.52		+£0
Yr 6 projected avg monthly profit	£594.85	(16.3%)	-£13.89
Total Dividends	£1,343.15		+£0
Total Profit from sales	£26,645.13		+£0
Average monthly cash profit	£393.75	(10.8%)	-£1.35
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	63%		+0%

Potential profits fell by £650 thanks to the drop in JLP:Jubilee Metals, but the rest of the portfolio dropped by an additional £1,000 thanks to OPTI:Optibiotix falling yet again. Long term performance is still above target.

Back to being closer to injection than cost.

At least this one is still just above the low of 3 weeks ago.

The SIPP looks like this after week 289 overall and week 29 of year 6.

			Weekly Change
Cash	£207.19		-£101.18
Portfolio cost	£73,175.51		+£379.63
Portfolio sell value (bid price - commission)	£57,550.91	(-21.4%)	-£1,691.57
Potential profits	£1,590.30		-£684.03
Yr 6 Dividends	£874.51		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£7,491.30		+£295.11
Yr 6 projected avg monthly profit	£1,232.53	(33.8%)	-£0.93
Total Dividends	£2,941.59		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£22,950.74		+£295.11
Average monthly cash profit	£377.17	(10.3%)	+£2.88
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	58%		+1%

Potential profits dropped by £684 as only CAML:Central Asia Metals and FXPO:Ferrexpo are in profit now. Fortunately most of my new magic formula shares are only down a few percent, so I'm hoping they will be in profit once spread and commission have cleared. Overall value fell further, mainly thanks to the drop in OPTI:Optibiotix.

The £295 (39.7%) profit was from selling another 400 shares in CAML:Central Asia Metals for 259.33p. I used the proceeds to buy 2,242 share in OPTI:Optibiotix costing £1,112.89. That takes me above 160,000 shares, so I think I really ought to stop now.

Long term performance remains above target, although will fall below target once the next pension transfer injection comes through. The absolutely great news is that my bond fund has increased enough to take me over the minimum £2,200 required to do a transfer this month. I just need to wait a few days for the payment to make it into the account, and then the 10 days it takes to transfer. If DDDD:4D Pharma stays around 100p I'll buy more of that, else magic formula shares. SBTX:SkinBioTherapeutics is still way to expensive to buy.

Even this is getting to the point where it is almost as close to the orange line as the red.

Total disaster - the worse it's been for 12 months.

The trading account looks like this after week 255 overall and week 47 of year 5.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,499.04	(-36.9%)	+£69.73
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£62.52	(31.6%)	-£1.39
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£17.03	(8.6%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

A good week thanks to DDDD:4D Pharma climbing 10%. It would have been better if the others hadn't dropped in value. Almost at the end of year 5 and no prospect of selling anything else this year. It will still be a record performance. 

A rare tick upwards!

My only hope is news from DDDD:4D Pharma as everything else is stuck in a hole.

Late writing my blog again this week, so nothing more to pontificate about.

Week 304 Review - Jubilee flys but it's not enough to stop a loss

It was looking like quite a good week but on the last few days there were small drops across some of my biggest holdings, compounded by cashing in some profit, so I ended up with the deficit between cost and value increasing by £2,042 to £27,864, but thanks to re-investing some profits the overall portfolio value only dropped by about half that to £118,607.

There were no big falls this week, but DDDD:4D Pharma dropping 4% and OPTI:Optibiotix dropping 1p was enough to do most of the damage.

JLP:Jubilee Metals makes up for being worst performer last week by smashing Share of the Week when it increased by 58% of my purchase price. It's now up by 357% and making £7,724 potential profit. However, I've done all the top slicing I want to, and plan to hold the last 50,000 shares longer term. Ideally it will be 100p a share before I sell any more, so I can get £1,000 by selling just 1,000 shares. Proper piggy bank!

Reasonably flat as the cost line goes up yet again.

Not as low as 2 weeks ago, so fingers crossed we'll be upwards again next week.

Here's the ISA and shares portfolio after week 44 of year 6.

			Weekly Change
Cash	£42.83		+£2.48
Portfolio cost	£70,691.67		+£0
Portfolio sell value (bid price-commission)	£57,705.35	(-18.4%)	+£55.51
Potential profits	£7,724.08		+£1,250.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£6,218.52		+£0
Yr 6 projected avg monthly profit	£608.74	(16.7%)	-£14.15
Total Dividends	£1,343.15		+£0
Total Profit from sales	£26,645.13		+£0
Average monthly cash profit	£395.10	(10.8%)	-£1.31
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	63%		+0%

This account actually went up by £55 thanks to JLP:Jubilee Metals shooting up by £1,250 and cancelling out the other losses. The increase was due to news of more tailings dumps secured for feeding the PGM circuits. Cash went up when I went into the account and added up what was actually there and found it was a few quid more than I thought. I haven't a clue why.

Completely flat.

Even the gloomy chart is flat this week.

The SIPP looks like this after week 288 overall and week 28 of year 6.

			Weekly Change
Cash	£308.37		-£210.05
Portfolio cost	£72,795.88		+£1,203.54
Portfolio sell value (bid price - commission)	£58,862.85	(-19.1%)	-£2,039.98
Potential profits	£2,274.33		-£787.38
Yr 6 Dividends	£874.51		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£7,196.19		+£1,010.19
Yr 6 projected avg monthly profit	£1,233.46	(33.8%)	+£116.39
Total Dividends	£2,941.59		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£22,655.63		+£1,010.19
Average monthly cash profit	£374.29	(10.3%)	+£13.94
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+2%

I decided to do what I mentioned last week and sacrifice some CAML:Central Asia Metals shares in order to get more magic formula shares, as this has been working really well but I had showing poor discipline in selling them to buy gut bacteria shares. Having said that, I also sacrificed a few more CAML for some more gut bacteria shares too!

I sold 300 CAML:Central Asia Metals shares for 279.7p making £280.20 (50.1%) profit. Combined with the cash from the CAML dividend I was able to buy 871 shares in CEY:Centamin at 114.71 costing £1,008.07.

On Friday I sold another 400 CAML shares at 277.2p and made £366.60 (49.3%) profit. I used the proceeds to buy another 2,373 shares in OPTI:Optibiotix at 50.184p costing £1,199.82 and bringing the average price in my SIPP down to 61.6p. My total OPTI:Optibiotix holding is now over 158,000 shares which gives me 8,000 shares I can play with to bank some profits while I keep the 150,000 long term.

The sales took me over my 10% target for long term performance for the first time in ages, and the performance over the first 6 months of year 6 has been spectacular. I suspect I won't be able to keep it up all year.

More of a dip as there was no JLP:Jubilee Metals to bail out the drops in this account.

That's a worry, as it's below the low from 2 weeks ago. It's my gut bacteria and gold shares letting me down.

The trading account looks like this after week 254 overall and week 46 of year 5.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,429.31	(-39.8%)	-£58.44
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£62.52	(31.6%)	-£1.39
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£17.03	(8.6%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

Everything in the account dropped this week, so it's looking somewhat grim.

Almost down to the injection line.

The only glimmer of hope is that the decline is less steep than the rise was. I don't think that means anything though, and it's not far from being below the 12-month low.

Shocking announcement from MTFB:Motif Bio this week. They are planning a share consolidation of one share for every 220 owned, resulting in under 3 million shares remaining, and then doing a thumping great share issue which effectively dilutes existing shareholders out of existence. I will have 34 shares costing £70 each. There's one thing I can guarantee, these shares are never getting to £70, so it's just a question of when I cut my losses. I guess it's better than losing everything, but a harsh lesson in the dangers of investing in junior pharma companies.

OPTI:Optibiotix results are due either next week or the week after. Not expecting any surprises in them, but it would be good to get them out of the way so we can prepare for the first Sweetbiotix news. I'm longing for that day...

Week 303 Review - Change of guard for the magic formula

A pretty steady week, helped massively by a 3p climb in OPTI:Optibiotix and cashing in my magic formula profits. The deficit between cost and value narrowed by £3,395 to £25,821 and total portfolio value went up to £119,655.

Biggest loser was JLP:Jubilee Metals again as no news causes much profit taking. It fell another 33% of my purchase price this week but is still 299% up.

The only other bad performer was a new purchase in my SIPP. PLUS:Plus500 came out right at the top of my share ranking spreadsheet so I bought some, but the combination of an inexplicable drop and spread and commission meant it fell 6% this week.

Share of the Week is my old favourite OPTI:Optibiotix, which climbed 5% and added just over £4,500. It's still 20% down and I still hope for news every morning that will see us higher.

A nice tick up

Somewhat relieved to have reversed the recent horrible drop - just hope it lasts

Here's the ISA and shares portfolio after week 43 of year 6.

			Weekly Change
Cash	£40.35		+£0
Portfolio cost	£70,691.67		+£0
Portfolio sell value (bid price-commission)	£57,649.84	(-18.4%)	+£1,923.27
Potential profits	£6,474.08		-£700.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£6,218.52		+£0
Yr 6 projected avg monthly profit	£622.89	(17.0%)	-£14.83
Total Dividends	£1,343.15		+£0
Total Profit from sales	£26,645.13		+£0
Average monthly cash profit	£396.41	(10.8%)	-£1.31
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	63%		+0%

A great improvement in value despite JLP:Jubilee Metals knocking £700 off the potential profits. It seems like ages since a good week for OPTI:Optibiotix, and it's a welcome sight. Long term performance still comfortably above target and will be by the end of year 6 even if I don't sell anything else, and year 6 performance guaranteed 14.1% unless something like MTFB:Motif Bio goes properly bust.

Still right between the red and orange lines

Will this be a reversal in fortunes or a brief blip?

The SIPP looks like this after week 287 overall and week 27 of year 6.

    

			Weekly Change
Cash	£518.42		+£162.71
Portfolio cost	£71,592.34		+£1,008.17
Portfolio sell value (bid price - commission)	£59,699.29	(-16.6%)	+£1,445.99
Potential profits	£3,061.71		-£843.98
Yr 6 Dividends	£874.51		+£280.00
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£6,186.00		+£890.89
Yr 6 projected avg monthly profit	£1,117.07	(30.6%)	+£152.19
Total Dividends	£2,941.59		+£280.00
Total Interest	£0.20		+£0
Total Profit from sales	£21,645.44		+£890.89
Average monthly cash profit	£360.35	(9.9%)	+£16.48
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	55%		+3%

A rather busy week. First of all there was a lovely £280 dividend from CAML:Central Asia Metals, then I sold APAX:Apax Global Alpha for 193.95p making £324.94 (31.7%) profit and POLR:Polar Capital Holdings for 801.3333p making £565.94 (55.8%) profit, as both were up for 12 month review and there were companies in my magic formula ranking higher than them.

The sale boosted my long term performance to 9.9% so only just below target, and year 6 performance is amazing 6 months into the year. I doubt I'll keep it up, but even if I don't sell another thing it will be 16.7% so well above target.

I used the proceeds from the sales to buy 3 new magic formula shares

Top of the ranking is now PLUS:Plus500 which I almost bought last time and wish I had. I think they were cheap because of concerns new regulations for letting people buy CFDs would hammer their profits. That hasn't happened, and they continue to be very cheap on a P/E ratio of 4.5, dividend yield of 8.29%, very high ROCE and virtually no debt. There's a big share buy-back programme at the moment and the share price has been pretty volatile, but I'm hopeful when I do the 12 month review it will be higher than this. I bought 63 shares at 1570.903p costing £1,001.62. 

Next purchase was FXPO:Ferrexpo. I was scared out of them by Russian troops building up on the Ukraine border, and happy to have banked profit. Now I'm back in again because despite recent rises, they are still number 2 in my ranking. I bought 226 shares at 441.3758p costing £1,014.45.

Finally I bought some more gold mine shares, with 58 shares of POLY:Polymetal at 1710.25p costing £1,003.90. Hopefully the gold price will continue to climb, especially as next on my list is CEY:Centamin, so I'm considering sacrificing a few CAML:Central Asia Metals shares to get back into that, as the tailings dam leak last year shows that even the best run mining company can have a disaster, so diversification is important even though I really like that company.

Still over half way up to the red line

The trend line is in danger of being flat in a few weeks

The trading account looks like this after week 253 overall and week 45 of year 5.

    

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,487.75	(-37.3%)	+£26.67
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£63.91	(32.3%)	-£1.45
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£17.09	(8.6%)	-£0.07
(Sold stocks profit + Dividends - Fees / Months)

Another nice tick upwards, but a long way to go before I can sell anything.

Has the rot stopped?

I need about £400 improvement to get above the trend line before it flattens.

Very late posting this week - a week late in fact!